Dr. Michael Forstner

Senior VP - Head of Risk Management and Pharmacoepidemiology

Dr. Michael Forstner is an expert in lifecycle benefit-risk management of medicines and post-approval studies of drug safety and efficacy.

Specialized in providing training and frequently lecturing on different PV topics. He is also leader of the PV WG of Medicines for Europe, representing the European generics and biosimilars industry at EMA meetings and in the CMDh Big Data taskforce. Michael has over 20 years of industry experience in various R&D, PV and managerial roles and in different companies ranging from small biotech to multinational biopharmaceutical enterprises. Before joining industry, he studied biochemistry and medicine in Graz, Austria, holds a PhD in biochemistry from ETH Zurich, did postdoctoral work at UC Berkeley, and was assistant professor at SLU Uppsala, Sweden

This site uses cookies to personalise and customise your experience. No cookies collect personal or sensitive information. By clicking “I Accept", you consent to cookies in accordance with our cookie policy.